Article

timesofisrael.com on 2019-04-20 04:15

Teva gets FDA approval for 1st generic nasal spray of overdose reversal drug

Israeli pharmaceutical company gets OK from US regulators for its version of Narcan

Related news

FDA OKs 1st generic nasal spray of overdose reversal drug Seattle Times
Israel
FDA OKs 1st generic nasal spray of overdose reversal drug - Fri, 19 Apr 2019 PST The Spokesman-Review
Israel , Cincinnati
MFDA approves first generic naloxone nasal spray to treat opioid overdose marketwatch.com
Israel
Teva Gets Approval to Sell Generic Nasal Spray for Opioid Overdoses wsj.com
Accused of complicity in opioid crisis, Teva launches nasal spray to treat overdose timesofisrael.com
Louisiana , Israel
Teva launches generic high blood pressure medicine bizjournals.com
North Wales , Israel
Marin drug company develops coronavirus nasal spray San Jose Mercury News
Ithaca , Netherlands , New York , Pacific Northwest , Madison
NFDA approves first over-the-counter nasal spray for opioid OD reversal nypost.com
California is joining with a New Jersey company to buy a generic opioid overdose reversal drug Seattle Times
New Jersey , California
BUK prof’s live-saving anti-overdose nasal spray on FDA fast track bizlex.com
Lexington , Phase 2
NFDA approves new nasal spray for untreatable depression nationalpost.com
New Jersey , Secaucus , New York , United States
MFDA approves Adapt Pharma's 2mg version of opioid overdose treatment Narcan Nasal Spray marketwatch.com
Pfizer migraine nasal spray snags FDA approval for summer launch Fox News
Stamford , New York
Teva shares jump as drugmaker gets nod for generic version of allergy EpiPen timesofisrael.com
New York , Israel , Tel Aviv